Tempus AI Stock Surges 82.4% in a Year: What's Driving It?

Key Takeaways TEM stock surged 82.4% in a year, sharply outperforming its industry peers and the broader market. TEM's Genomics sales more than doubled as testing volumes rose 33% and Ambry integration lifted efficiency. Data & Services revenues grew 26.1%, Paige boosted AI scale, and TEM posted positive adjusted EBITDA. Tempus AI (TEM) has shown impressive momentum in the past 12 months, with its shares rising 82.4%. This has significantly outperformed the industry, which grew 2.6%, as well as the S&P 500 ...